Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Gene Therapy
  4. Volume 25, Issue 2
  5. Article
Volume 25, Issue 2
  • ISSN: 1566-5232
  • E-ISSN: 1875-5631

Abstract

Oral Squamous Cell Carcinoma (OSCC) is a widespread and challenging disease that accounts for 94% of cancers of the oral cavity worldwide. Bacteriophages (phages) have shown promise as a potential theranostic agent for the treatment of OSCC. It may offer advantages in overcoming the challenges of conventional methods. Modern high-throughput pyrosequencing techniques confirm the presence of specific bacterial strains associated with OSCC. Bio-panning and filamentous phages facilitate visualization of the peptide on surfaces and show high affinity in OSCC cells. The peptide has the potential to bind integrin (αvβ6), aid in diagnosis, and inhibit the proliferation of OSCC cells. Mimotopes of tumor-associated antigens show cytotoxic and immune responses against cancer cells. Biomarker-based approaches such as transferrin enable early OSCC diagnosis. A modified temperate phage introduces CRISPR-Cas3 to target antimicrobial-resistant bacteria associated with OSCC. The research findings highlight the evolving field of phage diagnostics and therapy and represent a new avenue for non-invasive, targeted approaches to the detection and treatment of OSCC. However, extensive clinical research is required to validate the efficacy of phages in innovative cancer theranostic strategies.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cgt/10.2174/0115665232305905240521081553
2025-04-01
2025-01-18

  • From This Site

    /content/journals/cgt/10.2174/0115665232305905240521081553
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MarkopoulosA.K. Current aspects on oral squamous cell carcinoma.Open Dent. J.20126112613010.2174/1874210601206010126 22930665
     [Google Scholar]
  2. MuthusamyM. RamaniP. KrishnanP.R. K H, Sukumaran G, Ramasubramanian A. Oral microflora and its potential carcinogenic effect on oral squamous cell carcinoma: A systematic review and meta-analysis.Cureus2023151e3356010.7759/cureus.33560 36779115
     [Google Scholar]
  3. MachielsJ.P. LeemansR.C. GolusinskiW. GrauC. LicitraL. GregoireV. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann. Oncol.202031111462147510.1016/j.annonc.2020.07.011 33239190
     [Google Scholar]
  4. BorseV. KonwarA.N. BuragohainP. Oral cancer diagnosis and perspectives in India.Sensors Int.2020110004610.1016/j.sintl.2020.100046 34766046
     [Google Scholar]
  5. De FeliceF. TomboliniV. de VincentiisM. Multidisciplinary team in head and neck cancer: A management model.Med. Oncol.2019361210.1007/s12032‑018‑1227‑z 30426243
     [Google Scholar]
  6. SamiA. ElimairiI. StantonC. RossR.P. RyanC.A. The role of the microbiome in oral squamous cell carcinoma with insight into the microbiome–treatment axis.Int. J. Mol. Sci.20202121806110.3390/ijms21218061 33137960
     [Google Scholar]
  7. GongH. ShiY. XiaoX. Alterations of microbiota structure in the larynx relevant to laryngeal carcinoma.Sci. Rep.201771550710.1038/s41598‑017‑05576‑7 28710395
     [Google Scholar]
  8. SivaperumalP. KamalaK. Bacteriophages as novel tumor targeting therapy for oral squamous cell carcinoma (OSCC) cancer.Oral Oncol.202213310602010.1016/j.oraloncology.2022.106020 35853322
     [Google Scholar]
  9. HsiaoJ.R. ChangY. ChenY.L. Cyclic αvβ6‐targeting peptide selected from biopanning with clinical potential for head and neck squamous cell carcinoma.Head Neck201032216017210.1002/hed.21166 19572290
     [Google Scholar]
  10. RagothamanM. YooS.Y. Engineered phage-based cancer vaccines: Current advances and future directions.Vaccines202311591910.3390/vaccines11050919 37243023
     [Google Scholar]
  11. TavakoliF. GhavimiM.A. FakhrzadehV. AbdolzadehD. AfshariA. EslamiH. Evaluation of salivary transferrin in patients with oral squamous cell carcinoma.Clin. Exp. Dent. Res.202310e809 37964689
     [Google Scholar]
  12. NathA. BhattacharjeeR. NandiA. Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome.Biomed. Pharmacother.202215111312210.1016/j.biopha.2022.113122 35594718
     [Google Scholar]
/content/journals/cgt/10.2174/0115665232305905240521081553
Loading
Theranostic Potential of Bacteriophages against Oral Squamous Cell Carcinoma
Curr. Gene Ther. 25, 89 (2025); https://doi.org/10.2174/0115665232305905240521081553
/content/journals/cgt/10.2174/0115665232305905240521081553
/content/journals/cgt/10.2174/0115665232305905240521081553
Loading

Data & Media loading...


  • Article Type:     Editorial
Keyword(s): bacteriophage; CRISPR-Cas3; gene therapy; integrin (αvβ6); Oral squamous cell carcinoma; phage display peptide

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test